Chromatin remodeling with combined FACT and BET inhibition disrupts oncogenic transcription in Diffuse Midline Glioma
H. Holliday, A. Khan, A. Ehteda, H. Nguyen, S. E. Ross, N. Jayatilleke, A. Gopalakrishnan, E. Wang, Y. Colino Sanguino, D. Kavanagh, X. Guo, J. Liu, D. Lawrence, C. X. Sun, R. Lehmann, , D. S. Ziegler
This study shows that combining FACT and BET inhibition disrupts oncogenic transcription and extends survival in Diffuse Midline Glioma models.
bioRxiv · Jun 6, 2024 · PreprintCancer Biology